Natalie R Daya
Overview
Explore the profile of Natalie R Daya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
475
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Daya N, Fang M, Wang D, Valint A, Windham B, Coresh J, et al.
Diabetes Care
. 2024 Dec;
48(3):416-421.
PMID: 39705138
Objective: To characterize the prevalence of continuous glucose monitoring (CGM)-defined glucose abnormalities in a large, community-based population of very old adults (>75 years). Research Design And Methods: A cross-sectional analysis...
2.
Dooley S, Larbi Kwapong F, Col H, Turkson-Ocran R, Ngo L, Cluett J, et al.
Hypertension
. 2024 Dec;
82(2):382-392.
PMID: 39633562
Background: Orthostatic hypertension is an emerging risk factor for adverse events. Recent consensus statements combine an increase in blood pressure upon standing with standing hypertension, but whether these 2 components...
3.
Foti K, Wang D, Tang O, Daya N, Commodore-Mensah Y, Juraschek S, et al.
Hypertension
. 2024 May;
81(7):1599-1608.
PMID: 38690651
Background: Guidelines recommend antihypertensive medication for adults with both stage 1 hypertension (systolic blood pressure, 130-139 mm Hg or diastolic blood pressure, 80-89 mm Hg) and 10-year atherosclerotic cardiovascular disease...
4.
Mu S, Hicks C, Daya N, Foraker R, Kucharska-Newton A, Lutsey P, et al.
J Gen Intern Med
. 2024 Apr;
39(10):1850-1857.
PMID: 38598038
Background: Self-rated health is a simple measure that may identify individuals who are at a higher risk for hospitalization or death. Objective: To quantify the association between a single measure...
5.
Daya N, Fang M, Mathew M, Shin J, Pankow J, Lutsey P, et al.
Diabetes Care
. 2023 Dec;
47(2):e9-e10.
PMID: 38091486
No abstract available.
6.
Rooney M, Daya N, Leong A, McPhaul M, Shiffman D, Meigs J, et al.
J Diabetes Complications
. 2023 Aug;
37(9):108583.
PMID: 37579708
We found that individuals in the top tertile of HOMA-IR and with HbA1c-defined prediabetes have elevated risk of cardiometabolic outcomes.
7.
Kondo J, Earle W, Turkson-Ocran R, Ngo L, Cluett J, Lipsitz L, et al.
Am J Hypertens
. 2023 Jul;
36(11):593-601.
PMID: 37458702
Background: ACC/AHA guidelines caution against the use of antihypertensive therapy in the setting of low standing systolic BP (SBP) < 110 mm Hg due to unclear benefits. Methods: The Atherosclerosis...
8.
Daya N, McEvoy J, Christenson R, Tang O, Foti K, Juraschek S, et al.
Am J Hypertens
. 2023 Jul;
36(11):602-611.
PMID: 37458697
Background: The prognostic utility of NT-proBNP in the setting of hypertension has not been well-characterized in the general US adult population. Methods: We measured NT-proBNP in stored blood samples collected...
9.
Ozkan B, Grams M, Coresh J, McEvoy J, Echouffo-Tcheugui J, Mu S, et al.
Am Heart J
. 2023 Jun;
264:49-58.
PMID: 37290699
Background: NT-proBNP is an important predictor of mortality but is inversely related to estimated glomerular filtration rate (eGFR). Whether the prognostic value of NT-proBNP is similar at different levels of...
10.
Daya N, McEvoy J, Christenson R, Tang O, Foti K, Juraschek S, et al.
medRxiv
. 2023 Mar;
PMID: 36865209
Background: The prognostic utility of NT-proBNP in the setting of hypertension has not been well-characterized in the general US adult population. Methods: We measured NT-proBNP among adults aged 20 years...